Virtus LifeSci Biotech Products ETF (BBP)Health | Exchange Traded Fund | NYSEArca
98.10 USD
-2.16
(-2.151%) ⇩
(July 13, 2026, 3:58 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 5:23 a.m. EDT
The immediate outlook is driven by a powerful technical rebound. After languishing near the $60 level for years, the ETF has surged past its 52-week highs, trading at the top end of its range. The price action over the last two weeks shows aggressive buying, pushing the share price up significantly from the 50-day average. This momentum suggests smart money is rotating into small-cap biotech exposure, viewing the recent dip as a buying opportunity. However, the long-term picture remains murky due to a lack of income; there are no dividends to provide a floor or yield. While the recent price surge indicates the market is optimistic about the sector's recovery, the absence of a multi-year growth trajectory in the underlying data keeps the long-term conviction moderate. |
| Model | MAE |
|---|---|
| MSTL_90_126 ✓ | 0.037689 |
| MSTL_126 | 0.037712 |
| AutoTheta | 0.038031 |
| AutoARIMA | 0.039353 |
| AutoETS | 0.039458 |
| MSTL | 0.040153 |
| MSTL_90 | 0.045742 |
Forecast horizon: 60 days | Selected: MSTL_90_126
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 10.99 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.005 |
| Excess Kurtosis | 0.29 |
As of July 11, 2026, 5:23 a.m. EDT: Options activity is extremely thin with negligible volume and open interest across all expirations. Put writers are hedging near the $80-$85 range, while call buyers are virtually absent. The lack of speculative positioning suggests a wait-and-see approach rather than a strong directional bet.
| Date | Dividend | Yield % |
|---|---|---|
| 2017-12-20 | 0.072 | 0.181041 |
| 2015-12-21 | 0.397 | 1.306136 |
| Attribute | Value |
|---|---|
| All Time High | 105.21 |
| All Time Low | 21.47 |
| Ask | 146.97 |
| Ask Size | 200 |
| Average Daily Volume10 Day | 13,050 |
| Average Daily Volume3 Month | 9,806 |
| Average Volume | 9,806 |
| Average Volume10Days | 13,050 |
| Beta3 Year | 0.76 |
| Bid | 0.0 |
| Bid Size | 200 |
| Category | Health |
| Crypto Tradeable | 0 |
| Currency | USD |
| Custom Price Alert Confidence | HIGH |
| Day High | 98.8 |
| Day Low | 97.59 |
| Dividend Date | 1,514,332,800 |
| Dividend Yield | 0.0 |
| Esg Populated | 0 |
| Exchange | PCX |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 89.88368 |
| Fifty Day Average Change | 8.21962 |
| Fifty Day Average Change Percent | 0.091447294 |
| Fifty Two Week Change Percent | 60.811413 |
| Fifty Two Week High | 105.21 |
| Fifty Two Week High Change | -7.106697 |
| Fifty Two Week High Change Percent | -0.06754773 |
| Fifty Two Week Low | 60.91 |
| Fifty Two Week Low Change | 37.193302 |
| Fifty Two Week Low Change Percent | 0.6106272 |
| Fifty Two Week Range | 60.91 - 105.21 |
| First Trade Date Milliseconds | 1,418,826,600,000 |
| Five Year Average Return | 0.1373824 |
| Full Exchange Name | NYSEArca |
| Fund Family | Virtus |
| Fund Inception Date | 1,418,688,000 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Has Pre Post Market Data | 1 |
| Language | en-US |
| Legal Type | Exchange Traded Fund |
| Long Business Summary | Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing. |
| Long Name | Virtus LifeSci Biotech Products ETF |
| Market | us_market |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_274653437 |
| Nav Price | 100.24926 |
| Net Assets | 86,779,832.0 |
| Net Expense Ratio | 0.34 |
| Open | 99.63 |
| Phone | (212) 593-4383 |
| Previous Close | 100.26 |
| Price Hint | 2 |
| Quote Source Name | Delayed Quote |
| Quote Type | ETF |
| Region | US |
| Regular Market Change | -2.1567 |
| Regular Market Change Percent | -2.15111 |
| Regular Market Day High | 98.8 |
| Regular Market Day Low | 97.59 |
| Regular Market Day Range | 97.59 - 98.8 |
| Regular Market Open | 99.63 |
| Regular Market Previous Close | 100.26 |
| Regular Market Price | 98.1033 |
| Regular Market Time | 1,783,972,723 |
| Regular Market Volume | 16,497 |
| Short Name | Virtus Biotech ETF |
| Source Interval | 15 |
| Symbol | BBP |
| Three Year Average Return | 0.2272818 |
| Total Assets | 86,779,832 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Trailing Three Month Nav Returns | 15.47821 |
| Trailing Three Month Returns | 15.47821 |
| Triggerable | 1 |
| Two Hundred Day Average | 82.08597 |
| Two Hundred Day Average Change | 16.017334 |
| Two Hundred Day Average Change Percent | 0.19512877 |
| Type Disp | ETF |
| Volume | 16,497 |
| Yield | 0.0 |
| Ytd Return | 20.89033 |